SEC Filing Summary for Elanco Animal Health Inc.

This filing details a transaction by Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc. On April 3, 2026, Mr. Simmons acquired 123.8795 Deferred Stock Units, with each unit representing the right to one share of the Company's common stock or its cash equivalent. The acquisition price per unit was $22.82. Following this transaction, Mr. Simmons holds 23,919.1498 Deferred Stock Units. These units are set to settle in cash or shares of Company common stock subsequent to his termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan. The filing, designated as Form 4, was signed on April 7, 2026, by Amy C. Seidel as Attorney-in-Fact for Mr. Simmons.